Ontology highlight
ABSTRACT: Background
Diabetic ketoacidosis (DKA) is an acute, major, life-threatening complication of diabetes that requires immediate treatment. Allergic reaction to insulin is rare, especially when using recombinant human insulin. The clinical presentation of insulin allergy can range from minor local symptoms to a severe generalized allergic reaction such as anaphylaxis. A limited number of cases have been reported on the treatment of severe DKA in patients with type 2 diabetes with insulin allergy. Here, we describe a patient with type 2 diabetes with insulin allergy in which severe DKA resolved after the initiation of continuous intravenous (IV) recombinant human insulin infusion.Case presentation
A 58-year-old man with type 2 diabetes initiated subcutaneous insulin administrati
SUBMITTER: Nguyen AD
PROVIDER: S-EPMC6849168 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature